02/28/2011
https://www.congress.gov...
"How can you guys say--how can you stand here now and apologize--which I think it is great."
"You were very involved after you started--when you did your SEC filing in March, you were sending emails back and forth in July giving them PR advice, approving press releases."
"I think it is misleading to act as if this is a problem with four drugs. This is the business model."
"I just wanted to make sure that clearly if you are--what did you say, second? Second largest shareholder in Valeant and you want to talk about drug pricing in Congress, lobbying."